Search results for "slas europe 2018"

25

Refine your search

Explore by Field
Browse by Techniques

Search

Selected Filters:



Editorial Article

What next for CRISPR after first therapeutic approvals?

As we celebrate the first regulatory approval of a gene-editing based therapeutic, Casgevy™, for the treatment of sickle cell disease and transfusion-dependent β-thalassemia, we consider the gene-editing challenges that must be overcome before CRISPR gene-editing technology becomes a common treatment modality




















GMP Human IL-4 Protein

ACROBiosystems

Interleukin-4 (IL-4), also known as B cell-stimulatory factor-1, is a monomeric, approximately 13 kDa‑18 kDa Th2 cytokine that shows pleiotropic effects during immune responses.Due to its role in the differentiation of certain immune cell types, IL-4 is commonly used in combination with other growth factors to transform induced pluripotent stem cells into dendritic cells in high numbers.

0.0/5.0
|0 Reviews
Request Pricing

Industry News

Call for Applications!

Apply for the 2nd Annual Thermo Scientific Tandem Mass Tag Research Award